USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
28-Dec-2006
Europe
Market Research
B796-01-00-00-00
HC01173-EU-MR_05270
This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
Executive Summary
- Executive Summary
Important Terms
- Definitions
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Research Methodology
Methodology Of Research
- The "12 Step" Market Engineering Research Methodology and Process
Overview
- Market Analysis
- Scope and Objectives
- Pricing and Reimbursement
- The Biosimilars Opportunity
Pharmaceutical Cost-containment Measures
- Reference Pricing
- Parallel Trade
- Generic Substitution
- Patient Co-payments and Reimbursement
Political/Legal/Regulatory Issues
- Impact of EU Accession
- The Roche/Bolar Provision
- Data Exclusivity and Marketing Authorisation Applications
Group I
Group II
- Denmark
- Germany
- The Netherlands
- The United Kingdom
Group III
- Austria
- Belgium
- France
- Italy
- Portugal
- Spain
Market Players
Recommendations to Market Participants
DSDs
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B796-01-00-00-00 |
| Is Prebook | No |
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
$4,950.00
Special Price $3,712.50 save 25 %